Unlicensed Imported Medicines
key details
| Value | £83,000,000 (£100,000,000 inc. VAT) |
|---|---|
| Status | planned |
| Category (CPV) | 33600000 +1 more |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-051ff1 |
description
To provide a safe, cost effective framework for Imported Unlicensed Medicines – medicines originating into the UK which has marketing authorisation and is licensed in the country of origin but does not have a UK marketing authorisation. This framework will provide centralised quality assurance for these medicines to ensure they are assessed in a safe, consistent manner and reducing duplication of assessments currently undertaken by individual Trusts
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 23 May 2025 | Pipeline notice (UK1) | Procurement Act 2023 | 025534-2025 |
| 26 May 2026 | Pipeline notice (UK1) | Procurement Act 2023 | 048504-2026 |
more from East Of England NHS Collaborative Hub
- Roadside Assistance & Vehicle Recovery & Associated Services · £7,000,000 · 18 Jun 2026
- Independent Learning Responses Framework · £20,000,000 · 10 Jun 2026
- EoECPH Aseptic Cleanroom Consumables and Laundry Services. · £15,000,000 · 3 Jun 2026
- Aseptic Cleanroom Consumables and Laundry Services. · £12,000,000 · 26 May 2026
- Statutory & Multi-Specialty Audit Services & Advisory Consultancy Services · £60,000,000 · 26 May 2026
- Transforming Organisations, Partnerships, and Systems · £64,000,000 · 26 May 2026
- Social Impact Framework - Reopening 1 · £15,000,000 · 12 May 2026
- Training and Development Services · £8,333,333 · 20 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.